Phase I Clinical Trial of Human Vascular Endothelial Growth Factor Receptor 1 Peptide Vaccines for Patients With Metastatic Renal Cell Carcinoma

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2013.90
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome

Archives of Rheumatology
Rheumatology
2019English

Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2015English

A Phase I/Ii Trial of BNC105P With Everolimus in Metastatic Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2015English

Predicting Postoperative Recurrence of Renal Cell Carcinoma Using Serum Vascular Endothelial Growth Factor

Japanese Journal of Urology
Urology
2013English

Prognostic Significance of Serum Hepatocyte Growth Factor in Clear Cell Renal Cell Carcinoma: Comparison With Serum Vascular Endothelial Growth Factor

Journal of Medical Investigation
BiochemistryMedicineGeneticsMolecular Biology
2008English

Clinical Phase I Study With an Insulin-Like Growth Factor-1 Receptor Inhibitor: Experiences in Patients With Squamous Non-Small Cell Lung Carcinoma

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2010English

Biological Aspects and Binding Strategies of Vascular Endothelial Growth Factor in Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2007English

Vascular Endothelial Growth Factor Receptor-1 Modulates Vascular Endothelial Growth Factor-Mediated Angiogenesis via Nitric Oxide

American Journal of Pathology
Forensic MedicinePathology
2001English

Human Herpesvirus-8-Transformed Endothelial Cells Have Functionally Activated Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor

American Journal of Pathology
Forensic MedicinePathology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy